High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas

PURPOSE: Patients with non-Hodgkin lymphoma (NHL) have a median age of 67, with 70% surviving over 5 years. Chemotherapy for aggressive NHL includes cyclophosphamide, anthracycline, and high doses of corticosteroids, which can impair bone health. By reviewing clinical characteristics and standard-of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Li-Wen, Sun, Dong, Link, Thomas M., Lang, Thomas, Ai, Weiyun, Kaplan, Lawrence D., Steinman, Michael A., Andreadis, Charalambos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295123/
https://www.ncbi.nlm.nih.gov/pubmed/33694088
http://dx.doi.org/10.1007/s00520-021-06120-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295123/
https://www.ncbi.nlm.nih.gov/pubmed/33694088
http://dx.doi.org/10.1007/s00520-021-06120-0

Ejemplares similares